BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Reduces Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp reduced its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.8% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 59,183 shares of the medical equipment provider’s stock after selling 8,708 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp’s holdings in Intuitive Surgical were worth $29,075,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Ridgewood Investments LLC purchased a new stake in shares of Intuitive Surgical in the second quarter valued at approximately $26,000. Godsey & Gibb Inc. boosted its stake in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the last quarter. LRI Investments LLC purchased a new stake in Intuitive Surgical in the 1st quarter valued at $30,000. LGT Financial Advisors LLC increased its stake in shares of Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 54 shares during the last quarter. Finally, MidAtlantic Capital Management Inc. purchased a new position in shares of Intuitive Surgical during the 3rd quarter worth $33,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Up 0.6 %

Shares of ISRG opened at $542.00 on Friday. The company has a market cap of $193.05 billion, a P/E ratio of 87.14, a PEG ratio of 5.30 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $304.50 and a fifty-two week high of $552.00. The firm’s 50 day moving average price is $510.03 and its 200 day moving average price is $468.41.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Research analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Robert Desantis sold 238 shares of the stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $477.50, for a total value of $113,645.00. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,629,115. This represents a 4.14 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 50,459 shares of company stock valued at $26,080,251 in the last quarter. Corporate insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on the stock. Mizuho upped their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. JPMorgan Chase & Co. increased their price target on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Robert W. Baird lifted their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Citigroup increased their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Finally, Redburn Atlantic upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and lifted their target price for the company from $380.00 to $510.00 in a research report on Friday, August 2nd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $526.06.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.